Gary Hattersley is CSO at Nuvation Bio Inc. (NUVB). They have made 1 open-market trade across 1 company since 2015, most recently 2026-08-19.
CIK 0001521111
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NUVB | 100,000 | $443K |
| RDUS | 10,428 | $313K |
| Total | $756K |
Shares reported on the most recent Form 4, priced at the 2026-08-21 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NUVB | SELL · 10b5-1 | 2026-08-19 | 2026-08-21 | $7.09 | $709K | +2.7% | -10.5% | — |
| NUVB | SELL | 2025-11-20 | 2025-11-24 | $7.23 | $3.2M | +14.5% | +27.4% | -26.9% |
| NUVB | SELL · 10b5-1 | 2025-10-27 | 2025-10-29 | $5.02 | $1.0M | -9.2% | +57.1% | +9.8% |
| RDUS | SELL · 10b5-1 | 2015-11-12 | 2015-11-13 | $75.00 | $426K | -33.2% | -2.6% | -56.4% |
| RDUS | SELL · 10b5-1 | 2015-11-03 | 2015-11-05 | $70.00 | $933K | -33.2% | -2.6% | -47.6% |
| RDUS | SELL · 10b5-1 | 2015-10-23 | 2015-10-27 | $65.00 | $735K | -33.2% | -2.6% | -42.1% |
| RDUS | SELL · 10b5-1 | 2015-10-21 | 2015-10-23 | $65.36 | $98K | -33.2% | -2.6% | -43.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.